Company RBC Bioscience Corporation
Equities
6848
TW0006848005
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.85 TWD | -1.05% |
|
+11.21% | +16.36% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Reagent
69.7
%
| 128 | 73.8 % | 120 | 69.7 % | -6.43% |
Instrument
26.0
%
| 44 | 25.3 % | 45 | 26.0 % | +1.96% |
Others
4.3
%
| 2 | 0.9 % | 7 | 4.3 % | +392.96% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
65.0
%
| 105 | 60.5 % | 112 | 65.0 % | +6.54% |
Asia
10.5
%
| 20 | 11.3 % | 18 | 10.5 % | -8.12% |
Africa
9.6
%
| 10 | 5.9 % | 17 | 9.6 % | +61.26% |
Taiwan
8.5
%
| 20 | 11.5 % | 15 | 8.5 % | -26.70% |
Americas
6.4
%
| 19 | 10.8 % | 11 | 6.4 % | -41.04% |
Australia
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +983.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Wei Zhuo
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tsun Yuan Cho
BRD | Director/Board Member | - | - |
Ming Wei Zhuo
CEO | Chief Executive Officer | - | - |
Jun Yong Zhuo
BRD | Director/Board Member | - | - |
Ke Xin Zhan
BRD | Director/Board Member | - | - |
Kai Min Wang
BRD | Director/Board Member | - | - |
Ya Ting Zhuo
BRD | Director/Board Member | - | - |
Peng Lin Chen
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,975,600 | 9,276,256 ( 71.49 %) | 0 | 71.49 % |
Company contact information
RBC Bioscience Corp.
3rd Floor No. 132 Lane 235, Baoqiao Road
231 45, New TaiPei
+
http://www.rbcbioscience.com![address RBC Bioscience Corporation(6848)](https://cdn.zonebourse.com/static/address/128506335.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.36% | 7.57M | |
-5.35% | 179B | |
-5.23% | 98.81B | |
-7.75% | 64.7B | |
+17.84% | 44.56B | |
-9.21% | 44.06B | |
+8.09% | 43.8B | |
+11.97% | 28.28B | |
+20.27% | 25.89B | |
-5.34% | 23.41B |
- Stock Market
- Equities
- 6848 Stock
- Company RBC Bioscience Corporation